Joint Translational Grant Program
The Vascular Medicine Institute (VMI) is pleased to announce a new translational grant program in collaboration with the Coulter TPII Program (Coulter) at the University of Pittsburgh. In June of 2017, VMI/Coulter will award up two $50,000 grants, aimed at developing the commercial potential of healthcare solutions that are based on innovative technologies in the areas of:
- Transfusion medicine
- Hemostasis and platelet biology
- Integrative vascular biology
- Remedial devices or therapies targeting the vasculature
Projects may be medical devices, diagnostics, healthcare IT or drug delivery systems.
Ultimately, our mission is to provide awardees with the means to develop a viable path to commercialization via a license to an existing commercial entity or the initiation of a startup company through Pitt’s Innovation Institute. The Coulter team will provide guidance, project management support and personnel resources to assist this process. Grant awards will be based upon consideration for potential patient benefit, impact on the healthcare system, likelihood of technical success, economic viability, timeline to commercialization, and product scalability, all of which may significantly influence future adoption potential when the technology is commercialized.
As with other Coulter projects, each proposal must include a scientific co-principal investigator (Co-PI) and at least one clinical practitioner Co-PI from the Schools of the Health Sciences or UPMC, whose job responsibilities include direct contact with patients or patient data. University of Pittsburgh faculty members at the levels of assistant or research assistant professor, associate or research associate professor, and professor or research professor are eligible to apply as Co-PI’s. Instructors, fellows, research associates, predoctoral and postdoctoral researchers may also apply, providing there is a qualified faculty member who participates as a Co-PI.
The application process for this program begins with the submission of a letter of intent (LOI)
which is due by 5:00 pm on Tuesday, November 1, 2016.
Please direct questions to:
- Mark Gladwin, MD, Director, VMI at email@example.com
- Max Fedor, MBA, Coulter Program Director at firstname.lastname@example.org
- Lindsay Rodzwicz, Coulter Program Manager at email@example.com
Further details for the VMI/Coulter grant application may be found HERE.